Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Risk Score for Asthma Exacerbation (RSE)

    Predicts likelihood of asthma exacerbation within 6 months.
    Favorite
    When to Use
    Pearls/Pitfalls
    Why Use

    Patients with poorly-controlled asthma.

    • The Risk Score for Asthma Exacerbation (RSE) suggests which patients will experience an asthma exacerbation within 6 months.
    • The RSE should be further studied - while its validation was large, it was not validated outside of its own derivation cohort.
    • It was developed from pharmaceutical trials of patients with poorly controlled asthma, so it may not be applicable to patients with milder asthma severity.

    A score to help determine likelihood of exacerbation may assist in guiding therapy and/or monitoring.

    No
    0
    Yes
    +14
    < 1.5
    0
    1.5-2.5
    +7
    ≥2.5
    +13
    ≥90%
    0
    80% to 90%
    +13
    <80%
    +20
    <2
    0
    2-4
    +11
    ≥4
    +26
    No
    0
    Yes
    +27

    Result:

    Please fill out required fields.

    Next Steps
    Evidence
    Creator Insights

    Advice

    The RSE has been developed from a large cohort and now requires testing through validation studies.

    About the Creator
    Dr. Eric Bateman
    Are you Dr. Eric Bateman?